1. Development and validation of wide spectrum of analytical assays for various drug substances and drug products
Techniques used: HPLC, LC-MS, LC-MS/MS, GC-MS
Alera Labs specializes in developing and validating a wide range of analytical assays specifically tailored for the medical devices industry, ensuring accurate and reliable analysis of drug substances and products used in devices.
Alera Labs, a trusted provider of analytical chemistry services, specializes in developing and validating a diverse range of analytical assays specifically designed for the medical devices industry. Our expertise spans multiple techniques, including High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), and Gas Chromatography-Mass Spectrometry (GC-MS). These cutting-edge techniques enable us to deliver accurate and reliable analysis of drug substances and products used in medical devices.
As a leading laboratory in the medical devices industry, we understand the critical importance of ensuring the safety, efficacy, and quality of drug substances and products integrated into medical devices. Our team of experienced scientists and analytical experts is dedicated to providing comprehensive analytical solutions tailored to the unique requirements of the medical devices industry.
With our HPLC, LC-MS, LC-MS/MS, and GC-MS capabilities, we develop and validate a wide spectrum of analytical assays. These assays cover various drug substances and products, enabling us to assess their chemical composition, purity, and quality. By employing these advanced techniques, we can identify and quantify target compounds, detect impurities, and ensure the accurate determination of moisture content.
At Alera Labs, our commitment to quality and reliability is paramount. All our analytical assays undergo rigorous development, validation, and quality control processes to ensure the accuracy and precision of the results. We adhere to industry regulations and guidelines, implementing robust quality assurance measures at every stage of the analysis.
Our tailored analytical solutions for the medical devices industry extend beyond drug substance and product analysis. We also offer expertise in method development, method validation, stability testing, impurity identification, and regulatory compliance support. These services provide valuable insights into the safety, performance, and regulatory compliance of medical devices integrating drug substances or products.
With Alera Labs as your trusted partner, you can rely on our expertise and advanced analytical capabilities to ensure the accurate and reliable analysis of drug substances and products used in medical devices. Our dedication to quality, precision, and regulatory compliance sets us apart, making us the preferred choice for analytical chemistry services in the medical devices industry.
2. Forced degradation studies and stability indicating assays development
Techniques used: HPLC, GC-MS, LC-MS, LC-MS/MS
The team conducts forced degradation studies and develops stability indicating assays to assess the stability and integrity of drug substances and products used in medical devices.
Alera Labs, a provider of analytical chemistry services, specializes in conducting forced degradation studies and developing stability indicating assays specifically tailored for the medical devices industry. Our team of experts utilizes advanced techniques, including High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), to assess the stability and integrity of drug substances and products used in medical devices.
Forced degradation studies are essential in evaluating the stability of drug substances and products under various stress conditions, such as temperature, light, humidity, and pH. These studies provide valuable insights into the degradation pathways, degradation products, and potential interactions that may occur over time. By subjecting the substances and products to accelerated degradation conditions, we can simulate the degradation processes and assess their impact on the stability and quality of the medical devices.
In addition to forced degradation studies, our team specializes in developing stability indicating assays. These assays are designed to accurately and precisely measure the stability of drug substances and products used in medical devices over time. By establishing specific analytical methods and parameters, we can identify and quantify the target compounds, degradation products, and impurities that may be present. These stability indicating assays provide crucial information for monitoring the shelf-life and maintaining the efficacy and safety of the medical devices.
At Alera Labs, we understand the significance of stability and integrity in the medical devices industry. Our forced degradation studies and stability indicating assays are conducted in compliance with industry regulations and guidelines to ensure reliable and comprehensive results. We employ state-of-the-art techniques and follow stringent quality control procedures to deliver accurate and precise analytical data.
With our expertise in HPLC, GC-MS, LC-MS, and LC-MS/MS, we offer comprehensive analytical solutions for the medical devices industry. Our services extend beyond forced degradation studies and stability indicating assays to include method development, method validation, impurity identification, and regulatory compliance support. These services aid in the characterization, quality control, and regulatory approval of drug substances and products integrated into medical devices.
Partnering with Alera Labs ensures that your medical devices meet the highest standards of stability, integrity, and quality. Our commitment to excellence, scientific expertise, and advanced analytical techniques make us a trusted choice for the medical devices industry. Contact us today to benefit from our forced degradation studies and stability indicating assay development services tailored to your specific needs.
3. Elution studies (in vitro release studies) for slow release (controlled release) devices
Techniques used: HPLC, LC-MS, LC-MS/MS
Alera Labs performs elution studies to evaluate the release profiles of slow-release or controlled-release devices, providing valuable data on drug release kinetics and ensuring product effectiveness.
Alera Labs, a trusted provider of analytical chemistry services for the medical devices industry, specializes in performing elution studies, also known as in vitro release studies. These studies are specifically designed to evaluate the release profiles of slow-release or controlled-release devices, providing valuable data on drug release kinetics and ensuring the effectiveness of the product.
Using advanced techniques such as High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), and Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), our team conducts rigorous elution studies to assess the release characteristics of drugs from medical devices. These studies involve subjecting the devices to simulated physiological conditions, allowing us to measure and analyze the release of drugs over time.
By accurately quantifying the concentration of the released drug using HPLC, LC-MS, or LC-MS/MS techniques, we can generate comprehensive release profiles that provide insights into the drug release kinetics of the slow-release or controlled-release devices. This information is critical for understanding the device’s performance, determining its efficacy, and ensuring that it meets the desired release specifications.
Our experienced scientists work closely with medical device manufacturers to develop customized elution study protocols that align with regulatory guidelines and industry standards. We meticulously analyze the released drug samples using our advanced analytical instruments and apply rigorous quality control measures to ensure accurate and reliable results.
At Alera Labs, we understand the importance of elution studies in evaluating the performance and safety of slow-release or controlled-release devices. Our expertise in HPLC, LC-MS, and LC-MS/MS enables us to deliver precise and detailed data on drug release kinetics, helping our clients make informed decisions regarding their medical device formulations.
By partnering with Alera Labs for elution studies, you can rely on our commitment to excellence, scientific expertise, and state-of-the-art techniques. We prioritize quality control and regulatory compliance, ensuring that our analytical services meet the highest industry standards.
Contact Alera Labs today to benefit from our expertise in elution studies for slow-release or controlled-release devices. Our team is dedicated to providing accurate and reliable data that supports the development, quality control, and regulatory compliance of medical devices in the healthcare industry.
4. Stability testing
Techniques used: HPLC, GC-MS, LC-MS, LC-MS/MS
The company’s stability testing services help assess the shelf-life and performance of medical devices, ensuring their durability and functionality over time.
Alera Labs, a trusted provider of analytical chemistry services in the medical device industry, offers comprehensive stability testing services to assess the shelf-life and performance of medical devices. With our expertise and advanced techniques, including High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), we ensure the durability and functionality of medical devices over time.
Stability testing is a critical aspect of medical device development and quality control. It involves subjecting devices to various environmental conditions, such as temperature, humidity, light exposure, and mechanical stress, to simulate real-life usage scenarios and determine their long-term performance and stability.
At Alera Labs, we understand the importance of accurate and reliable stability testing for medical devices. Our skilled team of scientists and technicians designs customized stability study protocols that align with industry standards and regulatory requirements. We have a diverse range of fully qualified analytical instruments, including HPLC, GC-MS, LC-MS, and LC-MS/MS, to analyze the device components, materials, and formulations.
Using HPLC, GC-MS, LC-MS, and LC-MS/MS techniques, we evaluate the chemical composition, integrity, and degradation of medical device components and materials. Our stability testing services help identify any potential changes, such as degradation, impurities, or material deterioration, that may occur during the device’s expected shelf-life. By monitoring these changes, we can assess the device’s performance, reliability, and safety over time.
Alera Labs prioritizes the highest standards of quality and accuracy in stability testing. All data generated during stability studies undergoes multiple levels of review and quality assurance audits to ensure reliability and compliance. We provide comprehensive stability reports that outline the findings and recommendations for our clients, supporting their regulatory submissions and quality control processes.
By partnering with Alera Labs for stability testing, medical device manufacturers can have confidence in the durability and performance of their products. Our expertise in HPLC, GC-MS, LC-MS, and LC-MS/MS, combined with our commitment to quality, ensures that our stability testing services meet the specific needs and requirements of the medical device industry.
Contact Alera Labs today to leverage our expertise in stability testing for medical devices. Our dedicated team is ready to assist you in assessing the shelf-life and performance of your devices, ensuring their durability, functionality, and regulatory compliance.
5. Extractables and leachables studies following ISO10993, Biocompatibility studies
Techniques used: HPLC, GC-MS, LC-MS, LC-MS/MS,
Following ISO10993 guidelines, Alera Labs conducts studies to evaluate the potential migration of substances from medical devices, assessing their biocompatibility and safety.
Alera Labs, a trusted analytical chemistry service provider in the medical device industry, specializes in conducting extractables and leachables studies following ISO10993 guidelines. These studies are crucial in assessing the potential migration of substances from medical devices and evaluating their biocompatibility and safety.
It is essential to thoroughly investigate the extractables and leachables from medical devices to ensure patient safety and regulatory compliance. Alera Labs utilizes advanced techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Gass Chromatography (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), to conduct these studies.
Extractables studies involve identifying and quantifying the potential chemical compounds that can be released from the medical device materials when subjected to various conditions. Alera Labs employs HPLC, GC-MS, LC-MS, LC-MS/MStechniques to analyze and characterize these extractable compounds.
Leachables studies focus on evaluating the actual migration of these identified compounds from the medical device into surrounding environments or biological systems. By using advanced analytical techniques, including HPLC, GC-MS, LC-MS, LC-MS/MSAlera Labs can accurately detect and quantify leachable substances that may pose a risk to patients or impact the device’s performance.
Biocompatibility studies are an essential aspect of medical device development and regulatory approval. Alera Labs conducts comprehensive biocompatibility assessments to ensure that medical devices are compatible with living tissues and pose minimal risks to patients. These studies involve evaluating the interactions between the device and biological systems, assessing cytotoxicity, sensitization, irritation, and other relevant parameters.
By following ISO10993 guidelines, Alera Labs ensures that extractables and leachables studies and biocompatibility studies are conducted systematically and in compliance with industry standards. Our experienced team of scientists and technicians are well-versed in these studies, utilizing state-of-the-art techniques and equipment to provide accurate and reliable results.
At Alera Labs, we prioritize patient safety and regulatory compliance in the medical device industry. Our extensive expertise in HPLC, GC-MS, LC-MS, LC-MS/MScombined with our commitment to quality, enables us to deliver comprehensive extractables and leachables studies and biocompatibility studies for medical devices.
Partnering with Alera Labs for extractables and leachables studies and biocompatibility studies ensures that medical device manufacturers can evaluate the potential migration of substances, assess biocompatibility, and demonstrate the safety and efficacy of their products. Contact Alera Labs today to leverage our expertise and ensure the biocompatibility and safety of your medical devices in accordance with ISO10993 standards.
6. Method optimization, troubleshooting, and transfer
Techniques used: HPLC, GC-MS, LC-MS, LC-MS/MS
The team optimizes, troubleshoots, and facilitates the transfer of analytical methods, ensuring accurate and reliable analysis for the medical devices industry.
Alera Labs, a trusted provider of analytical chemistry services in the medical device industry, excels in method optimization, troubleshooting, and method transfer to ensure accurate and reliable analysis.
Our experienced team of scientists and technicians utilizes a range of cutting-edge techniques, including High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), to optimize analytical methods for medical device analysis.
Method optimization involves fine-tuning analytical methods to enhance their efficiency, sensitivity, and selectivity. By leveraging our expertise in HPLC, GC-MS, LC-MS, and LC-MS/MS, we can optimize the parameters, such as column selection, mobile phase composition, and detection settings, to ensure optimal separation and detection of target analytes in medical devices.
In case of any challenges or issues encountered during the analysis, our team is skilled in troubleshooting. We systematically investigate and resolve issues related to method performance, instrument functionality, or sample preparation, ensuring the reliability and accuracy of the analytical results.
Alera Labs also facilitates the transfer of analytical methods, ensuring seamless integration and implementation of established methods in different laboratories or manufacturing sites within the medical device industry. Our expertise in HPLC, GC-MS, LC-MS, and LC-MS/MS, coupled with our understanding of method transfer requirements, allows us to streamline the process and ensure consistent and reliable analysis across different facilities.
We prioritize accuracy, reliability, and efficiency in all aspects of method optimization, troubleshooting, and transfer. By employing our technological capabilities and industry knowledge, we ensure that analytical methods are robust, precise, and aligned with the specific requirements of the medical device industry.
Partnering with Alera Labs for method optimization, troubleshooting, and transfer offers numerous benefits to medical device manufacturers. Our expertise in HPLC, GC-MS, LC-MS, and LC-MS/MS, combined with our commitment to quality and customer satisfaction, ensures that analytical methods are optimized for efficient analysis, issues are promptly resolved through effective troubleshooting, and methods are seamlessly transferred to different laboratory settings.
Contact Alera Labs today to leverage our expertise in method optimization, troubleshooting, and transfer, and enhance the accuracy and reliability of your analytical analysis in the medical device industry.
7. Development, validation, and sample analysis for dose verification testing for GLP toxicology studies
Techniques used: HPLC, GC, LC-MS, LC-MS/MS
Alera Labs provides comprehensive services for the development, validation, and sample analysis of dose verification tests, ensuring accurate measurement of drug doses in GLP toxicology studies for medical devices.
Alera Labs is a trusted partner in the medical device industry, offering comprehensive services for the development, validation, and sample analysis of dose verification tests for GLP toxicology studies.
Our team of experienced scientists and technicians utilizes advanced techniques, including High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), to support accurate measurement of drug doses in GLP toxicology studies for medical devices.
The development phase involves designing and optimizing dose verification tests tailored to the specific requirements of GLP toxicology studies. By leveraging our expertise in HPLC, GC, LC-MS, and LC-MS/MS, we ensure that the tests are robust, precise, and capable of accurately quantifying drug doses in various medical device samples.
Validation is a critical step to establish the reliability and accuracy of the developed dose verification tests. Our team meticulously validates the methods, assessing parameters such as linearity, precision, accuracy, and selectivity, to ensure they meet the required regulatory standards and guidelines for GLP toxicology studies.
Once the dose verification tests are developed and validated, we perform sample analysis using HPLC, GC-MS, LC-MS, and LC-MS/MS techniques. Our state-of-the-art instrumentation and expert analysts enable us to accurately measure drug doses in medical device samples, providing essential data for GLP toxicology studies.
At Alera Labs, we adhere to the principles of Good Laboratory Practice (GLP) to ensure the integrity and reliability of our results. Our laboratory facilities are equipped with cutting-edge analytical instruments and follow rigorous quality control processes to maintain the highest standards of accuracy and precision.
By partnering with Alera Labs for the development, validation, and sample analysis of dose verification tests, medical device manufacturers can confidently assess the safety and efficacy of their products in GLP toxicology studies. Our expertise in HPLC, GC-MS, LC-MS, and LC-MS/MS, combined with our commitment to quality and regulatory compliance, ensures accurate measurement of drug doses, contributing to the overall success of GLP toxicology studies.
Contact Alera Labs today to leverage our comprehensive services for the development, validation, and sample analysis of dose verification tests, and ensure accurate measurement of drug doses in GLP toxicology studies for your medical devices.
8. Development and validation of bioassays for pharmacokinetics studies
Techniques used: HPLC, LC-MS, LC-MS/MS
The company’s expertise includes the development and validation of bioassays to study pharmacokinetics, providing valuable insights into the absorption, distribution, metabolism, and excretion of drugs used in medical devices.
Alera Labs is a trusted partner in the medical device industry, specializing in the development and validation of bioassays for pharmacokinetics studies.
Our experienced team of scientists and researchers utilizes advanced techniques, including High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), and Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), to design and validate bioassays that provide valuable insights into the pharmacokinetics of drugs used in medical devices.
The development of bioassays involves the careful design and optimization of experimental protocols tailored to the specific pharmacokinetic parameters of interest. By leveraging our expertise in HPLC, LC-MS, and LC-MS/MS, we ensure that the bioassays are sensitive, selective, and capable of accurately measuring drug concentrations in various biological matrices.
Validation is a crucial step to establish the reliability and accuracy of the developed bioassays. Our team rigorously validates the methods, assessing parameters such as sensitivity, precision, accuracy, linearity, and specificity, to ensure they meet the required regulatory standards and guidelines.
Once the bioassays are developed and validated, we conduct sample analysis using HPLC, LC-MS, and LC-MS/MS techniques. Our state-of-the-art instrumentation and skilled analysts enable us to accurately quantify drug concentrations in biological samples, providing valuable data on the absorption, distribution, metabolism, and excretion of drugs used in medical devices.
At Alera Labs, we prioritize quality and scientific rigor. Our laboratory facilities are equipped with cutting-edge analytical instruments and adhere to stringent quality control processes to ensure the accuracy and reliability of our results. We follow industry best practices and regulatory guidelines to deliver bioassays that meet the highest standards of excellence.
By partnering with Alera Labs for the development and validation of bioassays for pharmacokinetics studies, medical device manufacturers can gain valuable insights into the behavior and fate of drugs in the body. This information aids in optimizing drug delivery, understanding the systemic effects of drugs, and ensuring the safety and efficacy of medical devices.
Contact Alera Labs today to leverage our expertise in developing and validating bioassays for pharmacokinetics studies using HPLC, LC-MS, and LC-MS/MS techniques. Our dedicated team is ready to support your research and provide valuable insights into the pharmacokinetics of drugs used in medical devices.
9. Structure elucidation and Impurity Identification
Techniques used: HPLC, LC-MS, LC-MS/MS, FT-IR, GC-MS, 1D and 2D NMR
Alera Labs utilizes advanced techniques to elucidate chemical structures and identify impurities, supporting the characterization and quality control of drug substances and products used in medical devices.
Alera Labs is a trusted partner in the medical device industry, specializing in structure elucidation and impurity identification services.
Our experienced team of scientists utilizes a wide range of advanced techniques, including High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), Liquid Chromatography with tandem Mass SpectrometryLC-MS/MS, Fourier Transform Infrared Spectroscopy (FT-IR), and Gas Chromatography-Mass Spectrometry (GC-MS), and 1D and 2 D Nuclear Magnetic Resonance (NMR) to elucidate the chemical structures of drug substances and identify impurities.
Structure elucidation involves the analysis and interpretation of spectroscopic data obtained from techniques such as FT-IR, which provides valuable information about the functional groups and molecular structure of compounds. Our experts use this information to determine the chemical structure of drug substances used in medical devices.
Impurity identification is a critical aspect of quality control in the medical device industry. We employ techniques such as HPLC, LC-MS, LC-MS/MS, GC-MS, and NMR to separate, detect, and identify impurities present in drug substances and products used in medical devices. By utilizing these advanced techniques, we can accurately identify and quantify impurities, ensuring the safety and efficacy of medical devices.
Our laboratory facilities are equipped with state-of-the-art instrumentation, allowing us to perform comprehensive analyses and deliver accurate results. We follow rigorous quality control processes to ensure the reliability and traceability of our data.
By partnering with Alera Labs for structure elucidation and impurity identification, medical device manufacturers can gain valuable insights into the chemical composition of drug substances and ensure the quality and purity of their products. Our services support the characterization, quality control, and regulatory compliance of drug substances and products used in medical devices.
Contact Alera Labs today to leverage our expertise in structure elucidation and impurity identification using HPLC, LC-MS, LC-MS/MS, FT-IR, GC-MS, NMR techniques. Our dedicated team is ready to support your research and provide accurate and reliable results for the characterization and quality control of drug substances and products used in medical devices.
10. Formulation development for various drug products (excipient screening, excipient compatibility, and stability)
Techniques used: HPLC, GC-MS, LC-MS, LC-MS/MS
The company offers formulation development services specific to the medical devices industry, including excipient screening, excipient compatibility, and stability studies to optimize the formulation of drug products used in medical devices.
Alera Labs is a trusted provider of formulation development services for the medical device industry. Our specialized expertise lies in developing optimized formulations for various drug products used in medical devices.
Using advanced techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS), we offer a comprehensive range of formulation development services tailored to the specific needs of medical device manufacturers.
One of our key services is excipient screening, where we carefully select and evaluate excipients to ensure their compatibility with the drug substances used in medical devices. Through rigorous analysis using HPLC, GC-MS, LC-MS, LC-MS/MS, and other appropriate techniques, we assess the compatibility of excipients, enabling us to choose the most suitable ones for the formulation.
Additionally, we conduct excipient compatibility studies to examine the stability and interaction between drug substances and excipients. By utilizing advanced analytical techniques, we can identify any potential incompatibilities or degradation pathways that may arise during the formulation process. This allows us to optimize the formulation to ensure the stability and effectiveness of the drug product.
Furthermore, our stability studies play a vital role in the formulation development process. By subjecting the drug products to various conditions, we evaluate their stability over time. We employ the Karl Fischer method to determine the moisture content, a critical parameter that can impact the stability and shelf-life of the formulation.
Our formulation development services are conducted with utmost precision and adherence to regulatory guidelines. We prioritize quality control and regulatory compliance to ensure the safety and efficacy of the final product.
Partnering with Alera Labs for formulation development in the medical device industry provides you with the expertise and analytical capabilities necessary to optimize the formulation of drug products. Our HPLC, GC-MS, LC-MS, LC-MS/MS method techniques, combined with our extensive experience, enable us to deliver customized formulation solutions that meet the specific requirements of medical devices.
Contact Alera Labs today to leverage our formulation development services for excipient screening, excipient compatibility, and stability studies. Our dedicated team is committed to providing high-quality, reliable, and tailored formulation solutions to meet the unique needs of the medical device industry.